Terms of Use
PlainPharmaWatch presents pharmaceutical payment data from the U.S. CMS Open Payments program for informational and educational use only. Nothing here is medical, legal, or financial advice, and a reported payment does not by itself imply wrongdoing by any physician, hospital, or manufacturer. These terms set out acceptable use, attribution, and the limits of our liability; the underlying figures and their caveats are documented in our methodology.
Acceptance
By using PlainPharmaWatch, you agree to these terms. If you disagree, please discontinue use.
Data Accuracy
PlainPharmaWatch reproduces payment records published through the CMS Open Payments program for Program Year 2024. Manufacturer reporting corrections, physician name changes, and CMS data refresh cycles may affect the figures shown. No warranty of completeness or precision is made.
Not Professional Advice
PlainPharmaWatch is not a government agency. Content does not constitute medical, financial, legal, or policy advice. Receiving payments from pharmaceutical companies is legal and does not imply wrongdoing.
Copyright and Attribution
The underlying data is public domain (U.S. government work). Our presentation, design, and analysis are copyrighted. You may not scrape, reproduce, or redistribute our pages without permission.
Contact
Questions? Contact legal@plainpharmawatch.com.
Data Accuracy and Verification
PlainPharmaWatch aggregates and reformats information that originates from public government agencies, regulatory filings, and other openly available sources. While we take reasonable steps to ingest, normalize, and refresh this data, upstream records may contain clerical errors, lag behind real-world changes, or omit relevant context. You are solely responsible for verifying any fact that influences a legal, medical, financial, educational, safety, or similarly consequential decision. Cross-reference the official source before acting on anything you read here.
Acceptable Use
You may browse, read, and share PlainPharmaWatch content for personal, journalistic, academic, and non-commercial research use. You may cite specific records with attribution and a link back to the page on plainpharmawatch.com. You may not (a) systematically scrape, crawl, or download the dataset in bulk without prior written permission; (b) resell, sublicense, or redistribute derived data products that compete with PlainPharmaWatch; (c) use our pages to harass, defame, or misrepresent any individual or organization appearing in the data; (d) remove, obscure, or mislabel source attribution; or (e) attempt to bypass rate limits, security controls, or authentication mechanisms.
Plain-Language Editorial Role
PlainPharmaWatch combines raw public data with plain-language summaries, explainers, and comparisons. Narrative sections are drafted by our editorial team from official source data and reviewed for accuracy before publication. We do not modify the underlying numbers or filings — those are loaded directly from the upstream source. If you spot a summary that misreads the data, please email the correction link on our contact page.
Intellectual Property
The underlying public records surfaced on PlainPharmaWatch are in the public domain or otherwise freely licensed by the issuing agency — you are free to use those raw facts. However, our site design, layout, navigation structure, original editorial copy, category taxonomies, comparison tables, and curated rankings are the copyrighted work of Kiznis Studio. These creative elements may not be reproduced in whole or substantial part without permission.
Changes to These Terms
We may update these Terms of Use from time to time to reflect changes in our data sources, product features, legal environment, or advertising relationships. When we make material changes, we will update the "Last updated" date above and — when appropriate — surface a brief notice on the homepage. Continued use of the site after an update constitutes acceptance of the revised terms. We encourage you to revisit this page periodically.
Governing Law and Disputes
These terms are governed by the laws of the United States and the jurisdiction in which Kiznis Studio is domiciled, without regard to conflict-of-law principles. Any dispute arising from or relating to your use of PlainPharmaWatch will first be addressed through good-faith informal negotiation. If that fails, both parties agree to resolve the dispute in the courts with jurisdiction over Kiznis Studio's principal place of business. Nothing in these terms limits your statutory consumer-protection rights under applicable local law.
Legal Notices
For formal legal notices, DMCA takedown requests, subpoenas, law-enforcement requests, or correspondence regarding these terms, email legal@plainpharmawatch.com. General questions, data corrections, and feedback should use the contact page so they reach the editorial team promptly.